NT-I7 for Kaposi Sarcoma in Patients With or Without HIV

Complete Title: Phase 1 Study of NT-I7 (rhIL-7-hyFc) for the Treatment of Kaposi Sarcoma in Patients With or Without Infection with HIV

Trial Phase: I

Investigator: Manoj Menon

This phase I trial studies the best dose and effects of NT-I7 in treating Kaposi sarcoma in patients with or without HIV. NT-I7 works by using a patient`s immune system to fight cancer. It is made in a laboratory and is used to boost, direct, or restore the body`s natural defenses against cancer. NT-I7 may work better in treating Kaposi sarcoma.

Keywords:

Sarcoma
HIV Infections

Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.

Join a Clinical Trial

Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each clinical trial.

Contact Us

If you are seeking to schedule an appointment, we are here to help. You can either call us or fill out our online appointment request form.